DORCHESTER WEALTH MANAGEMENT Co Cuts Position in Mettler-Toledo International Inc. (NYSE:MTD)

DORCHESTER WEALTH MANAGEMENT Co lessened its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 4.9% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 2,065 shares of the medical instruments supplier’s stock after selling 107 shares during the quarter. DORCHESTER WEALTH MANAGEMENT Co’s holdings in Mettler-Toledo International were worth $3,097,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Family Firm Inc. purchased a new position in Mettler-Toledo International during the 2nd quarter valued at approximately $25,000. Blue Trust Inc. boosted its holdings in shares of Mettler-Toledo International by 242.9% in the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 17 shares during the period. Rothschild Investment LLC purchased a new position in shares of Mettler-Toledo International in the 2nd quarter worth approximately $42,000. Itau Unibanco Holding S.A. purchased a new position in shares of Mettler-Toledo International in the 2nd quarter worth approximately $42,000. Finally, Crewe Advisors LLC boosted its holdings in shares of Mettler-Toledo International by 244.4% in the 2nd quarter. Crewe Advisors LLC now owns 31 shares of the medical instruments supplier’s stock worth $43,000 after purchasing an additional 22 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Analyst Upgrades and Downgrades

MTD has been the subject of several recent research reports. StockNews.com raised Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Thursday, July 11th. Stifel Nicolaus boosted their target price on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the stock a “buy” rating in a research note on Monday, August 5th. Wells Fargo & Company began coverage on Mettler-Toledo International in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $1,400.00 target price on the stock. The Goldman Sachs Group boosted their target price on Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 9th. Finally, Evercore ISI boosted their target price on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, Mettler-Toledo International currently has an average rating of “Hold” and an average target price of $1,363.75.

Insider Buying and Selling at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 250 shares of the stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total value of $350,250.00. Following the completion of the sale, the chief financial officer now owns 4,914 shares of the company’s stock, valued at approximately $6,884,514. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, insider Christian Magloth sold 1,000 shares of the stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the completion of the sale, the insider now owns 734 shares of the company’s stock, valued at approximately $1,044,459.98. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Shawn Vadala sold 250 shares of the stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total value of $350,250.00. Following the completion of the transaction, the chief financial officer now owns 4,914 shares of the company’s stock, valued at $6,884,514. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Price Performance

NYSE MTD traded down $7.00 during trading hours on Thursday, reaching $1,313.35. The company’s stock had a trading volume of 7,854 shares, compared to its average volume of 132,321. The firm has a market capitalization of $28.05 billion, a price-to-earnings ratio of 37.03, a P/E/G ratio of 4.24 and a beta of 1.14. Mettler-Toledo International Inc. has a 1-year low of $928.49 and a 1-year high of $1,546.93. The company’s 50-day moving average is $1,421.35 and its two-hundred day moving average is $1,394.57.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 EPS for the quarter, beating analysts’ consensus estimates of $9.00 by $0.65. Mettler-Toledo International had a negative return on equity of 575.61% and a net margin of 20.95%. The business had revenue of $946.75 million during the quarter, compared to analysts’ expectations of $929.13 million. During the same quarter in the prior year, the firm earned $10.19 earnings per share. The business’s revenue was down 3.6% compared to the same quarter last year. Equities analysts forecast that Mettler-Toledo International Inc. will post 40.35 EPS for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.